Erratum: Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies (Modern Rheumatology 10.1007/s10165-008-0139-8);Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies

Modern Rheumatology

Volumn 19, Issue 2, 2009, Pages 156-164

  Takada, Tetsuya ^a   Hirakata, Michito ^a   Suwa, Akira ^b   Kaneko, Yuko ^c   Kuwana, Masataka ^a   Ishihara, Tadayuki ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hakone National Hospital   (Japan)

Author keywords

Anti SRP antibodies; Dermatomyositis; Histopathology; Muscle biopsy; Myositis specific autoantibodies; Polymyositis

Indexed keywords

ALKALINE PHOSPHATASE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; MYOSIN ADENOSINE TRIPHOSPHATASE; RIBONUCLEOPROTEIN; SIGNAL RECEPTOR PARTICLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPRESSION FRACTURE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATORY INFILTRATE; JAPANESE; MALE; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PSYCHOSIS; RHEUMATOID ARTHRITIS;

EID: 64449085703     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0165-1     Document Type: Erratum

References (27)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
2. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007;19:523-9.
3. Mimori T. Stractures targeted by the immune system in myositis. Curr Opin Rheumatol. 1996;8:521-7.
4. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12:475-81.
5. Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: Changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol. 2004;16:692-9.
6. Love LA, Leff RL, Freser DD, Targoff IN, Darakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patients groups. Medicine (Baltimore). 1991;70:360-74.
7. Hirakata M. Humoral aspects of polymyositis/dermatomyositis. Mod Rheumatol. 2000;10:199-206.
8. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002;28:859-90.
9. Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007;56:1295-303.
10. Hirakata M, Mimori T, Akizuki A, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992;35:449-56.
11. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77:1019-38.
12. Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1986;2:499-516.
13. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci USA. 1986;83:9507-11.
14. Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA. Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. J Immunol. 1987;138:3219-23.
15. Targoff IN, Johnson AE, Miller FW. Autoantibodies to signal recognition particle in polymyositis. Arthritis Rheum. 1990;33:1361-70.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-7.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403-7.
18. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162:2315-20.
19. Dubowitz V, Sewry CA, Lane R. Definition of pathological changes seen in muscle biopsies. In: Dubowitz V, Sewry CA, Lane R, editors. Muscle biopsy a practical approach. 3rd ed. Philadelphia: (W.B.) Saunders; 2007. p. 91-2.
20. Dubowitz V, Sewry CA, Lane R. Histological and histochemical stains and reactions. In: Dubowitz V, Sewry CA, Lane R, editors. Muscle biopsy a practical approach. 3rd ed. Philadelphia: (W.B.) Saunders; 2007. p. 21-39.
21. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: Clinical and pathologic features. J Neurol Neurosurg Psychiatry. 2002;73:420-8.
22. Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalalas MC, et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991;34:1391-6.
23. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum. 2004;50:209-15.
24. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: Pathology in perimysium and neighbouring muscle fibers. J Neurol Neurosurg Psychiatry. 2000;68:472-8.
25. Hengstman GJ, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotizing myopathy. Ann Rheum Dis. 2006;65:1635-8.
26. Cavanagh NP, Lake BD, McMeniman P. Congenital fiber type disproportion myopathy. A histological diagnosis with an uncertain clinical outlook. Arch Dis Child. 1979;54:735-43.
27. Innaccone ST, Brove KE, Vogler CA, Buchino JJ. Type 1 fiber size disproportion: Morphometric data from 37 children with myopathic, neuropathic, or idiopathic hypotonia. Pediatr Pathol. 1987;7:395-419.